Motor System Activation With Transcranial Direct Current Stimulation and Physical Exercise to Reduce Pain in Elderly

March 24, 2023 updated by: Guillaume Léonard, Université de Sherbrooke

Activating Motor System to Relieve Pain in Elderly: What is the Role of Physical Exercise and Transcranial Stimulation

Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.

Study Overview

Detailed Description

Prevalence and intensity of chronic pain increases substantially with age. According to several studies, physical exercises are effective to reduce chronic pain in elderly. However, it seems that exercises are not effective for everyone. One of the hypotheses raised is that the people in whom the exercises have no effect would be those with an alteration of the corticospinal tract. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique known to facilitate the corticospinal tract when applied over the motor cortex.

Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Quebec
      • Sherbrooke, Quebec, Canada, J1H 4C4
      • Sherbrooke, Quebec, Canada, J1M 0C6
        • Recruiting
        • Grace Village
        • Contact:
          • Guillaume Léonard, pht, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • To have musculoskeletal chronic pain
  • Not to change medication and life habits during the study

Exclusion Criteria:

  • People physically active before the study (more then 150 min of moderate to vigorous exercise par week)
  • To have an uncontrolled cardiovascular disease
  • To have orthopedic limitation or contraindication to physical exercise
  • To have contraindication to tDCS
  • To have contraindication to TMS
  • To have contraindication to MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise + real tDCS

Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.

For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).

real tDCS sessions
Aerobic exercise and physical training combined with sham tDCS
Sham Comparator: Exercise + Sham tDCS

Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.

For the first week, participants will receive 5 daily sessions of sham tDCS.

Aerobic exercise and physical training combined with sham tDCS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Pain intensity
Time Frame: Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)
Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10
Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Corticospinal excitability (TMS)
Time Frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after
Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS)
Before intervention, Follow-up 1 week after, Follow-up 1 month after
Corticospinal excitability (dMRI)
Time Frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after
Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging
Before intervention, Follow-up 1 week after, Follow-up 1 month after
Functional connectivity
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Functional connectivity will be assessed with functional magnetic resonance imaging
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
McGill pain questionnaire
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome.
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Brief pain inventory
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck depression inventory
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck anxiety inventory
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Margolis pain drawing and scoring system
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Patient global impression of change questionnaire
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Tampa questionnaire
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Pain catastrophizing scale
Time Frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome
Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guillaume Léonard, pht, PhD., Université de Sherbrooke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

January 23, 2020

First Submitted That Met QC Criteria

April 2, 2020

First Posted (Actual)

April 3, 2020

Study Record Updates

Last Update Posted (Actual)

March 27, 2023

Last Update Submitted That Met QC Criteria

March 24, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on transcranial direct current stimulation

3
Subscribe